Specialty Pharmacy

Analysis confirms the safety and efficacy of palliative radiation therapy for painful bone metastases.

Grant E. Knowles, PharmD, vice president of Business Development at Ardon Health, discusses how specialty pharmacies can help patients access high cost specialty drugs.

Top news of the day from across the health care landscape.

Study finds syringe services outreach should be more focused on whites, who now make up a large portion of injection drug users.

Gilead’s antiretroviral medication associated with the increased risk of fracture in patients with HIV.

Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses how collaborative care programs among providers can benefit patients undergoing treatment.

MiniMed 670G significantly reduced HbA1c levels in adolescents and adults with type 1 diabetes.

Carcinoid syndrome affects some patients with carcinoid tumors.

Investigational drug treats patients with relapsed or refractory AML with an isocitrate dehydrogenase 2 mutation.

Top news of the day from across the health care landscape.

Combination therapy shows promise treating pancreatic cancer.

Investigational MS drug lowers the relapse rate during a phase 3 clinical trial.

G-CSF promotes regeneration of sperm cells in cancer patients.

A majority of glioblastomas change their genomic profile during therapy, new research finds.

Targeting the interactions between neurons and cancer cells may be a powerful strategy in future cancer treatments.

Fixed-dose combination provides another oral treatment option for patients with diabetes.

Alternating gut microbiota in mice causes hypertension.

Top news of the day from across the health care landscape.

Researchers create a map of breast cancer cell shapes and genes that is linked to outcomes.

One-fourth of standard dose with low-fat meal as effective as standard dose.

Biologic HIV drug may reduce new infections among high risk populations.

Marc O'Connor, COO and chief strategy officer at Curant Health, discusses how the shift to Medicare Part D could impact patients undergoing treatment for cancer.

The smallest Cas9 gene editing technique has been developed thus far.

Lynparza (olaparib) shows efficacy in a phase 3 clinical trial of BRCA-mutated HER2-negative metastatic breast cancer.

New technology can predict which patients will achieve remission and which will relapse.

Top news of the day from across the health care landscape.

Top news of the week in oncology and cancer drug development.

The Akt protein is crucial for T cells to transform into memory T cells.

Parameters used to calculate direct and indirect remuneration fees may not apply to specialty pharmacies.

SF2523 can dually inhibit a protein and an enzyme associated with cancer.